Global Parkinson's Disease Treatments Market Insights, Forecast to 2025

Publisher Name :
Date: 24-May-2019
No. of pages: 111
Inquire Before Buying

Parkinson's disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.

The global Parkinson's Disease Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Parkinson's Disease Treatments market based on company, product type, end user and key regions.

This report studies the global market size of Parkinson's Disease Treatments in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Parkinson's Disease Treatments in these regions.

This research report categorizes the global Parkinson's Disease Treatments market by top players/brands, region, type and end user. This report also studies the global Parkinson's Disease Treatments market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GSK

- Merck

- Novartis

- Teva

- Boehringer Ingelheim

- Impax

- Abbvie

- Valeant Pharmaceuticals

- Lundbeck

- Sun Pharma

- Wockhardt

- Acadia

- UCB

Market size by Product

- Dopamine Agonists

- Levodopa

- Glutamate Antagonist

- Apomorphine

- COMT Inhibitors Anticholinergics

- MAO-B Inhibitors

- Other Drugs

Market size by End User

- Hospitals

- Healthcare Institutes

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Parkinson's Disease Treatments market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Parkinson's Disease Treatments market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Parkinson's Disease Treatments companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Parkinson's Disease Treatments submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Parkinson's Disease Treatments are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parkinson's Disease Treatments market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Parkinson's Disease Treatments Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Parkinson's Disease Treatments Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Product
1.4.2 Dopamine Agonists
1.4.3 Levodopa
1.4.4 Glutamate Antagonist
1.4.5 Apomorphine
1.4.6 COMT Inhibitors Anticholinergics
1.4.7 MAO-B Inhibitors
1.4.8 Other Drugs
1.5 Market by End User
1.5.1 Global Parkinson's Disease Treatments Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Healthcare Institutes
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parkinson's Disease Treatments Market Size
2.1.1 Global Parkinson's Disease Treatments Revenue 2014-2025
2.1.2 Global Parkinson's Disease Treatments Sales 2014-2025
2.2 Parkinson's Disease Treatments Growth Rate by Regions
2.2.1 Global Parkinson's Disease Treatments Sales by Regions
2.2.2 Global Parkinson's Disease Treatments Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Parkinson's Disease Treatments Sales by Manufacturers
3.1.1 Parkinson's Disease Treatments Sales by Manufacturers
3.1.2 Parkinson's Disease Treatments Sales Market Share by Manufacturers
3.1.3 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson's Disease Treatments Revenue by Manufacturers
3.2.1 Parkinson's Disease Treatments Revenue by Manufacturers (2014-2019)
3.2.2 Parkinson's Disease Treatments Revenue Share by Manufacturers (2014-2019)
3.3 Parkinson's Disease Treatments Price by Manufacturers
3.4 Parkinson's Disease Treatments Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease Treatments Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease Treatments Product Type
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease Treatments Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Parkinson's Disease Treatments Sales by Product
4.2 Global Parkinson's Disease Treatments Revenue by Product
4.3 Parkinson's Disease Treatments Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Parkinson's Disease Treatments Breakdown Data by End User
6 North America
6.1 North America Parkinson's Disease Treatments by Countries
6.1.1 North America Parkinson's Disease Treatments Sales by Countries
6.1.2 North America Parkinson's Disease Treatments Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Parkinson's Disease Treatments by Product
6.3 North America Parkinson's Disease Treatments by End User
7 Europe
7.1 Europe Parkinson's Disease Treatments by Countries
7.1.1 Europe Parkinson's Disease Treatments Sales by Countries
7.1.2 Europe Parkinson's Disease Treatments Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parkinson's Disease Treatments by Product
7.3 Europe Parkinson's Disease Treatments by End User
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease Treatments by Countries
8.1.1 Asia Pacific Parkinson's Disease Treatments Sales by Countries
8.1.2 Asia Pacific Parkinson's Disease Treatments Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Parkinson's Disease Treatments by Product
8.3 Asia Pacific Parkinson's Disease Treatments by End User
9 Central & South America
9.1 Central & South America Parkinson's Disease Treatments by Countries
9.1.1 Central & South America Parkinson's Disease Treatments Sales by Countries
9.1.2 Central & South America Parkinson's Disease Treatments Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Parkinson's Disease Treatments by Product
9.3 Central & South America Parkinson's Disease Treatments by End User
10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease Treatments by Countries
10.1.1 Middle East and Africa Parkinson's Disease Treatments Sales by Countries
10.1.2 Middle East and Africa Parkinson's Disease Treatments Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Parkinson's Disease Treatments by Product
10.3 Middle East and Africa Parkinson's Disease Treatments by End User
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Parkinson's Disease Treatments Products Offered
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Parkinson's Disease Treatments Products Offered
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Parkinson's Disease Treatments Products Offered
11.3.5 Novartis Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Company Business Overview
11.4.3 Teva Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Parkinson's Disease Treatments Products Offered
11.4.5 Teva Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Impax
11.6.1 Impax Company Details
11.6.2 Company Business Overview
11.6.3 Impax Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Impax Parkinson's Disease Treatments Products Offered
11.6.5 Impax Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Company Business Overview
11.7.3 Abbvie Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbvie Parkinson's Disease Treatments Products Offered
11.7.5 Abbvie Recent Development
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Valeant Pharmaceuticals Parkinson's Disease Treatments Products Offered
11.8.5 Valeant Pharmaceuticals Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Company Business Overview
11.9.3 Lundbeck Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Lundbeck Parkinson's Disease Treatments Products Offered
11.9.5 Lundbeck Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Sun Pharma Parkinson's Disease Treatments Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sun Pharma Parkinson's Disease Treatments Products Offered
11.10.5 Sun Pharma Recent Development
11.11 Wockhardt
11.12 Acadia
11.13 UCB
12 Future Forecast
12.1 Parkinson's Disease Treatments Market Forecast by Regions
12.1.1 Global Parkinson's Disease Treatments Sales Forecast by Regions 2019-2025
12.1.2 Global Parkinson's Disease Treatments Revenue Forecast by Regions 2019-2025
12.2 Parkinson's Disease Treatments Market Forecast by Product
12.2.1 Global Parkinson's Disease Treatments Sales Forecast by Product 2019-2025
12.2.2 Global Parkinson's Disease Treatments Revenue Forecast by Product 2019-2025
12.3 Parkinson's Disease Treatments Market Forecast by End User
12.4 North America Parkinson's Disease Treatments Forecast
12.5 Europe Parkinson's Disease Treatments Forecast
12.6 Asia Pacific Parkinson's Disease Treatments Forecast
12.7 Central & South America Parkinson's Disease Treatments Forecast
12.8 Middle East and Africa Parkinson's Disease Treatments Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinson's Disease Treatments Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Parkinson's Disease Treatments Product Picture
Table Parkinson's Disease Treatments Market Segments
Table Key Manufacturers Parkinson's Disease Treatments Covered
Table Global Parkinson's Disease Treatments Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Parkinson's Disease Treatments Sales Market Share by Product 2014-2025
Figure Dopamine Agonists Product Picture
Table Major Manufacturers of Dopamine Agonists
Figure Levodopa Product Picture
Table Major Manufacturers of Levodopa
Figure Glutamate Antagonist Product Picture
Table Major Manufacturers of Glutamate Antagonist
Figure Apomorphine Product Picture
Table Major Manufacturers of Apomorphine
Figure COMT Inhibitors Anticholinergics Product Picture
Table Major Manufacturers of COMT Inhibitors Anticholinergics
Figure MAO-B Inhibitors Product Picture
Table Major Manufacturers of MAO-B Inhibitors
Figure Other Drugs Product Picture
Table Major Manufacturers of Other Drugs
Table Global Parkinson's Disease Treatments Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Healthcare Institutes
Figure Others
Figure Parkinson's Disease Treatments Report Years Considered
Figure Global Parkinson's Disease Treatments Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease Treatments Sales 2014-2025 (K Units)
Table Global Parkinson's Disease Treatments Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Parkinson's Disease Treatments Sales by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Treatments Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Treatments Sales Market Share by Regions 2014-2019
Figure 2018 Global Parkinson's Disease Treatments Sales Market Share by Regions
Table Global Parkinson's Disease Treatments Revenue by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease Treatments Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Treatments Revenue Market Share by Regions 2014-2019
Figure 2018 Global Parkinson's Disease Treatments Revenue Market Share by Regions
Table Global Parkinson's Disease Treatments Sales by Manufacturers (2014-2019) (K Units)
Table Global Parkinson's Disease Treatments Sales Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease Treatments Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Parkinson's Disease Treatments Revenue by Manufacturers (2014-2019) (Million USD)
Table Parkinson's Disease Treatments Revenue Share by Manufacturers (2014-2019)
Figure Parkinson's Disease Treatments Value Share by Manufacturers in 2018
Table Key Manufacturers Parkinson's Disease Treatments Price (2014-2019) (USD/Unit)
Table Parkinson's Disease Treatments Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Parkinson's Disease Treatments Product Type
Table Date of International Manufacturers Enter into Parkinson's Disease Treatments Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table Global Parkinson's Disease Treatments Sales Share by Product (2014-2019)
Figure Global Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure Global Parkinson's Disease Treatments Sales Market Share by Product in 2018
Table Global Parkinson's Disease Treatments Revenue by Product (2014-2019) (Million US$)
Table Global Parkinson's Disease Treatments Revenue Share by Product (2014-2019)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Product (2014-2019)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Product in 2018
Table Parkinson's Disease Treatments Price by Product 2014-2019 (USD/Unit)
Table Global Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table Global Parkinson's Disease Treatments Sales Share by End User (2014-2019)
Figure Global Sales Parkinson's Disease Treatments Market Share by End User (2014-2019)
Figure Global Sales Parkinson's Disease Treatments Market Share by End User in 2018
Figure North America Parkinson's Disease Treatments Sales Growth Rate 2014-2019 (K Units)
Figure North America Parkinson's Disease Treatments Revenue Growth Rate 2014-2019 (Million US$)
Table North America Parkinson's Disease Treatments Sales by Countries (2014-2019) (K Units)
Table North America Parkinson's Disease Treatments Sales Market Share by Countries (2014-2019)
Figure 2018 North America Parkinson's Disease Treatments Sales Market Share by Countries
Table North America Parkinson's Disease Treatments Revenue by Countries (2014-2019) (Million US$)
Table North America Parkinson's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Parkinson's Disease Treatments Revenue Market Share by Countries
Figure United States Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure United States Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Canada Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Table North America Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table North America Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure 2018 North America Parkinson's Disease Treatments Market Share by Product
Table North America Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table North America Parkinson's Disease Treatments Sales Market Share by End User (2014-2019)
Figure 2018 North America Parkinson's Disease Treatments Market Share by End User
Figure Europe Parkinson's Disease Treatments Sales Growth Rate 2014-2019 (K Units)
Figure Europe Parkinson's Disease Treatments Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Parkinson's Disease Treatments Sales by Countries (2014-2019) (K Units)
Table Europe Parkinson's Disease Treatments Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinson's Disease Treatments Sales Market Share by Countries
Table Europe Parkinson's Disease Treatments Revenue by Countries (2014-2019) (Million US$)
Table Europe Parkinson's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinson's Disease Treatments Revenue Market Share by Countries
Figure Germany Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Germany Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure France Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure France Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure UK Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Italy Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Russia Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table Europe Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure 2018 Europe Parkinson's Disease Treatments Market Share by Product
Table Europe Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table Europe Parkinson's Disease Treatments Sales Market Share by End User (2014-2019)
Figure 2018 Europe Parkinson's Disease Treatments Market Share by End User
Figure Asia Pacific Parkinson's Disease Treatments Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Parkinson's Disease Treatments Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Parkinson's Disease Treatments Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Parkinson's Disease Treatments Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease Treatments Sales Market Share by Countries
Table Asia Pacific Parkinson's Disease Treatments Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Parkinson's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease Treatments Revenue Market Share by Countries
Figure China Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure China Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Japan Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Korea Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure India Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure India Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Australia Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table Asia Pacific Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease Treatments Market Share by Product
Table Asia Pacific Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table Asia Pacific Parkinson's Disease Treatments Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease Treatments Market Share by End User
Figure Central & South America Parkinson's Disease Treatments Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Parkinson's Disease Treatments Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Parkinson's Disease Treatments Sales by Countries (2014-2019) (K Units)
Table Central & South America Parkinson's Disease Treatments Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinson's Disease Treatments Sales Market Share by Countries
Table Central & South America Parkinson's Disease Treatments Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinson's Disease Treatments Revenue Market Share by Countries
Figure Brazil Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table Central & South America Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Parkinson's Disease Treatments Market Share by Product
Table Central & South America Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table Central & South America Parkinson's Disease Treatments Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Parkinson's Disease Treatments Market Share by End User
Figure Middle East and Africa Parkinson's Disease Treatments Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Parkinson's Disease Treatments Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Countries
Table Middle East and Africa Parkinson's Disease Treatments Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease Treatments Revenue Market Share by Countries
Figure GCC Countries Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Parkinson's Disease Treatments Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Parkinson's Disease Treatments Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Parkinson's Disease Treatments Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Parkinson's Disease Treatments Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease Treatments Market Share by Product
Table Middle East and Africa Parkinson's Disease Treatments Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Parkinson's Disease Treatments Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease Treatments Market Share by End User
Table GSK Company Details
Table GSK Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Teva Company Details
Table Teva Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Impax Company Details
Table Impax Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Impax Recent Development
Table Abbvie Company Details
Table Abbvie Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Lundbeck Company Details
Table Lundbeck Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lundbeck Recent Development
Table Sun Pharma Company Details
Table Sun Pharma Parkinson's Disease Treatments Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharma Recent Development
Table Wockhardt Company Details
Table Acadia Company Details
Table UCB Company Details
Table Global Parkinson's Disease Treatments Sales Forecast by Regions 2019-2025 (K Units)
Table Global Parkinson's Disease Treatments Sales Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease Treatments Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Parkinson's Disease Treatments Revenue Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease Treatments Sales Forecast by Product 2019-2025 (K Units)
Table Global Parkinson's Disease Treatments Sales Market Share Forecast by Product 2019-2025
Table Global Parkinson's Disease Treatments Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Parkinson's Disease Treatments Revenue Market Share Forecast by Product 2019-2025
Table Global Parkinson's Disease Treatments Sales Forecast by End User 2019-2025 (K Units)
Table Global Parkinson's Disease Treatments Sales Market Share Forecast by End User 2019-2025
Figure North America Parkinson's Disease Treatments Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Parkinson's Disease Treatments Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Parkinson's Disease Treatments Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Parkinson's Disease Treatments Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Parkinson's Disease Treatments Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Parkinson's Disease Treatments Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Parkinson's Disease Treatments Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Parkinson's Disease Treatments Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Parkinson's Disease Treatments Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Parkinson's Disease Treatments Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Parkinson's Disease Treatments Value Chain
Table Parkinson's Disease Treatments Customers List
Table Parkinson's Disease Treatments Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Inorganic Copper Fungicides Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 163
    According to this latest study, the 2020 growth of Inorganic Copper Fungicides will have significant change from previous year. By the most conservative estimates of global Inorganic Copper Fungicides market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 690.6 million in 2019. Over the next five years the Inorganic Copper Fungicides market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 802.9 million by 2025.......
  • Global Jet Lag Treatment Market Growth (Status and Outlook) 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 118
    According to this latest study, the 2020 growth of Jet Lag Treatment will have significant change from previous year. By the most conservative estimates of global Jet Lag Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 382.1 million in 2019. Over the next five years the Jet Lag Treatment market will register a 4.4% CAGR in terms of revenue, the global market size will reach US$ 453.1 million by 2025. This report pre......
  • Global Levothyroxine Sodium Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 138
    According to this latest study, the 2020 growth of Levothyroxine Sodium will have significant change from previous year. By the most conservative estimates of global Levothyroxine Sodium market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 3365.7 million in 2019. Over the next five years the Levothyroxine Sodium market will register a 2.9% CAGR in terms of revenue, the global market size will reach US$ 3774.2 million by 2025. This......
  • Global Orally Disintegrating Tablet Excipient Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Orally Disintegrating Tablet Excipient will have significant change from previous year. By the most conservative estimates of global Orally Disintegrating Tablet Excipient market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 15380 million in 2019. Over the next five years the Orally Disintegrating Tablet Excipient market will register a 3.6% CAGR in terms of revenue, the global market size will ......
  • Global Oncaspar Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 134
    According to this latest study, the 2020 growth of Oncaspar will have significant change from previous year. By the most conservative estimates of global Oncaspar market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 205.7 million in 2019. Over the next five years the Oncaspar market will register a 11.8% CAGR in terms of revenue, the global market size will reach US$ 321.6 million by 2025. This report presents a comprehensive over......
  • Global Therapeutic Enzymes Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 165
    According to this latest study, the 2020 growth of Therapeutic Enzymes will have significant change from previous year. By the most conservative estimates of global Therapeutic Enzymes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8797.1 million in 2019. Over the next five years the Therapeutic Enzymes market will register a 12.6% CAGR in terms of revenue, the global market size will reach US$ 14120 million by 2025. This re......
  • Global Blood Banking and Blood Products Market Growth (Status and Outlook) 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 117
    According to this latest study, the 2020 growth of Blood Banking and Blood Products will have significant change from previous year. By the most conservative estimates of global Blood Banking and Blood Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 19490 million in 2019. Over the next five years the Blood Banking and Blood Products market will register a 1.9% CAGR in terms of revenue, the global market size will reach US$ 20990 mi......
  • Global Medical Specialty Enzymes Market Growth 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Medical Specialty Enzymes will have significant change from previous year. By the most conservative estimates of global Medical Specialty Enzymes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 724.3 million in 2019. Over the next five years the Medical Specialty Enzymes market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 900.8 million by 2025. ......
  • Global Ergothioneine (EGT) Market Growth (Status and Outlook) 2021-2026
    Published: 26-Jan-2021        Price: US 3660 Onwards        Pages: 115
    According to this latest study, the 2020 growth of Ergothioneine (EGT) will have significant change from previous year. By the most conservative estimates of global Ergothioneine (EGT) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8 million in 2019. Over the next five years the Ergothioneine (EGT) market will register a 33.3% CAGR in terms of revenue, the global market size will reach US$ 25 million by 2025. This report pre......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs